To what extent is mean EMG frequency during gait a reflection of functional muscle strength in children with cerebral palsy?
High EMG frequency during gait flags weak muscles more than fast walking in children with CP.
01Research in Context
What this study did
The team watched children with cerebral palsy walk in a 3-D gait lab.
They taped tiny EMG sensors to the gastrocnemius and hamstrings.
The goal: see if high muscle “buzz” frequency means weak strength or just fast walking.
What they found
Kids with weaker leg muscles showed higher EMG frequency while they walked.
Walking speed had less impact on the signal than strength did.
So a “noisy” muscle trace is more a red flag for weakness than for quick steps.
How this fits with other research
Keawutan et al. (2014) pooled ten studies and found the same link: better motor skill equals more daily movement.
Neyroud et al. (2017) looked at young adults and saw weaker but longer-lasting plantar flexors.
That seems opposite, but the 2017 study tested still legs, not walking; gait EMG captures a different weakness picture.
Verschuren et al. (2010) showed low aerobic capacity in the same group—another reminder that every body system lags in CP.
Why it matters
Next time you watch a gait report, look at the EMG trace before you look at speed.
If the lines are fast and jagged, suspect weak muscles, not fast walking, and plan strength work before endurance work.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Open the last gait report—circle any high-frequency EMG bursts and flag those muscles for strength training.
02At a glance
03Original abstract
The aim of the current paper was to analyze the potential of the mean EMG frequency, recorded during 3D gait analysis (3DGA), for the evaluation of functional muscle strength in children with cerebral palsy (CP). As walking velocity is known to also influence EMG frequency, it was investigated to which extent the mean EMG frequency is a reflection of underlying muscle strength and/or the applied walking velocity. Surface EMG data of the lateral gastrocnemius (LGAS) and medial hamstrings (MEH) were collected during 3DGA. For each muscle, 20 CP children characterized by a weak and 20 characterized by a strong muscle (LGAS or MEH) were selected. A weak muscle was defined as a manual muscle testing score <3; a strong muscle was defined as a manual muscle testing score ≥4. Patient selection was based on the following inclusion criteria: (a) predominantly spastic type of CP (3-15 years old), (b) either (near) normal muscle strength or muscle weakness in at least one of the studied lower limb muscles, (c) no lower limb Botulinum Toxin-A treatment within 6 months prior to the 3DGA, (d) no history of lower limb surgery, and (e) high-quality noise-free EMG-data. For each muscle, twenty age-related typically developing (TD) children were included as controls. In both muscles a consistent pattern of increasing mean EMG frequency with decreasing muscle strength was observed. This was significant in the LGAS (TD versus weak CP). Walking velocity also had a significant effect on mean EMG frequency in the LGAS. Furthermore, based on R(2) and partial correlations, it could be concluded that both walking velocity and muscle strength have an impact on EMG, but the contribution of muscle strength was always higher. These findings underscore the potential of the mean EMG frequency recorded during 3DGA, for the evaluation of functional muscle strength in children with CP.
Research in developmental disabilities, 2012 · doi:10.1016/j.ridd.2011.12.010